CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban

(MedPage Today) -- Faulty INR measurements didn't affect pivotal trial results, agency says
via CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban
by